Axonius Acquires Cynerio

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

Axion BioSystems Acquires CytoSMART Technologies

March 21, 2022

Medical Devices

Axion BioSystems has acquired Netherlands-based CytoSMART Technologies, a developer of kinetic live-cell imaging systems and AI-powered image analysis tools. The acquisition expands Axion's product portfolio and capabilities in live-cell imaging to support research in stem cell biology, immuno-oncology, cell-based therapies, and drug discovery.

ClinicalMind Acquires IC Axon

October 2, 2020

Healthcare Services

ClinicalMind, a healthcare communications firm, has acquired IC Axon, a Montreal-based developer of science-driven clinical and sales training for pharmaceutical, biotech and medical device companies. The deal adds IC Axon's digital learning and in-house clinical expertise (a team of over 90 employees) to ClinicalMind's strategic and tactical offerings to better support clients preparing for product launches and field-team training.

Axon to Acquire Dedrone

May 6, 2024

Aerospace & Defense

Axon has entered into a definitive agreement to acquire Dedrone, a global leader in airspace security and counter-drone solutions. The acquisition will expand Axon's public safety platform by integrating Dedrone's AI/ML-based detection, tracking and mitigation technologies; the deal is expected to close in the second half of 2024 (terms undisclosed).

Sorcero Acquires Axiom Health

July 16, 2025

AI & Machine Learning

Sorcero, an AI-driven life sciences analytics company, has acquired Axiom Health, a real-world data platform focused on the medical technology industry. The Axiom Health platform will be rebranded as Sorcero MedTech to unify medtech and pharmaceutical insights; the transaction was supported by a new investment from First Trust Capital Partners and additional investments from Axiom investors.

Route1 Inc. Acquires Spyrus Solutions, Inc.

September 15, 2021

Cybersecurity

Route1 Inc. acquired Spyrus Solutions, a San Jose developer and manufacturer of cryptographic products, for approximately US$0.58 million in cash or assumption of debt plus potential earnout payments tied to gross profit thresholds. The acquisition brings Spyrus' hardware and software cryptographic products and a core engineering team (seven employees added) into Route1 to expand its data security capabilities and product offerings for government, defense, financial and healthcare customers.